Koligo Therapeutics Ltd of SYDNEY, C3, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-20. The offering totals $400K, of which $38K was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Robert Clisdell | Director | Sydney NSW, C3 |
| Peter James | Director | Sydney, C3 |
| Matthew Lehman | Director | FARGO, ND |
| Jethro Marks | Director | Sydney NSW, C3 |
| Stuart Williams | Director | Sydney NSW, C3 |
| Matthew Lehman | Executive Officer | FARGO, ND |
| Ariel Sivikofsky | Executive Officer | NORTH SYDNEY NSW, C3 |
| Stuart Williams | Executive Officer | Sydney NSW, C3 |